Mahesh Karande

Public and Private Biotech CEO | Board Member| Georgia Institute of Technology | The Wharton School

Role
Member Board of Directors at Ksq Therapeutics, Inc
Location
Boston, MA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Mahesh Karande

Biotech Chief Executive - Private and Public.• Biotech boards – private and public (audit committee, comp committee, deal committee, R&D committee)• Extensive deal and BD experience• Raised Series A, B, C, IPO and follow-on financings• Biotech experience through early start-up and discovery phase through pre-clinical, clinical development• Pharma experience from P2 through launch, commercialization, large team and P&L management• Oncology, Immunology, Metabolic, Cardiovascular, Neurosciences, Respiratory, Critical/Acute Care, Drug-device combos• Managed $1.7Bn people• Extensive product launch experience• US, Switzerland, India, Egypt, Middle East, Asia-Pac, Africa and Europe

Experience

  1. Member Board of Directors

    Ksq Therapeutics, Inc

    Dec 2022 — Present · Boston, MA, US

    Private clinical-stage biotech company working on CRISPR/Cas9-engineered Tumor Infiltrating Lymphocytes (eTIL®) and first-in-class drug candidates for cancer.

Education

  • VJTI, University of Bombay

    Bachelor of Engineering - BE, Engineering

  • The Wharton School

    MBA, Finance, Strategy

  • Georgia Institute of Technology

    Master of Science - MS, Engineering

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mahesh Karande — Member Board of Directors at Ksq Therapeutics, Inc in Boston, MA, US | Unifers